Macquarie Group LTD Viking Therapeutics, Inc. Transaction History

Macquarie Group LTD

$86.4 Billion
Q4 2024

A detailed history of Macquarie Group LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 517,408 shares of VKTX stock, worth $16.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

517,408

Previous 568,400 8.97%

Holding current value

$16.4 Million

Previous $36 Million 42.14%

% of portfolio

0.02%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.28 - $78.03 $1.95 Million - $3.98 Million	-50,992 Reduced 8.97%	517,408 $20.8 Million
Q3 2024 Nov 14, 2024	SELL	$49.84 - $70.47 $15,251 - $21,563	-306 Reduced 0.05%	568,400 $36 Million
Q2 2024 Aug 09, 2024	BUY	$47.39 - $80.2 $4.35 Million - $7.36 Million	91,771 Added 19.24%	568,706 $30.1 Million
Q1 2024 May 14, 2024	BUY	$17.4 - $94.5 $2.55 Million - $13.9 Million	146,835 Added 44.48%	476,935 $39.1 Million
Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $4,110 - $6,136	-1,948 Reduced 0.59%	330,100 $954,000
Q1 2021 May 14, 2021	SELL	$5.74 - $9.67 $3,426 - $5,772	-597 Reduced 0.18%	332,048 $2.1 Million
Q2 2020 Aug 11, 2020	BUY	$4.35 - $8.08 $11,070 - $20,563	2,545 Added 0.77%	332,645 $2.4 Million
Q2 2019 Aug 14, 2019	SELL	$7.67 - $10.63 $553,820 - $767,549	-72,206 Reduced 17.95%	330,100 $2.74 Million
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $269,802 - $353,804	-35,594 Reduced 8.13%	402,306 $4 Million
Q4 2018 Feb 15, 2019	BUY	$7.16 - $16.21 $437,476 - $990,431	61,100 Added 16.22%	437,900 $3.35 Million
Q3 2018 Nov 15, 2018	BUY	$9.7 - $19.65 $452,989 - $917,654	46,700 Added 14.15%	376,800 $6.56 Million
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $1.28 Million - $4.21 Million	330,100 New	330,100 $3.13 Million
Q1 2018 May 11, 2018	SELL	$4.11 - $6.93 $8,631 - $14,553	-2,100 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$1.74 - $4.34 $3,654 - $9,114	2,100	2,100 $9,000

Others Institutions Holding VKTX

# of Institutions

466

Shares Held

65.8M

Call Options Held

5.84M

Put Options Held

3.76M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.43B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Viking Therapeutics, Inc. Transaction History